MY108437A - Imidazopyridine paf/h1 antagonists - Google Patents

Imidazopyridine paf/h1 antagonists

Info

Publication number
MY108437A
MY108437A MYPI92000223A MYPI19920223A MY108437A MY 108437 A MY108437 A MY 108437A MY PI92000223 A MYPI92000223 A MY PI92000223A MY PI19920223 A MYPI19920223 A MY PI19920223A MY 108437 A MY108437 A MY 108437A
Authority
MY
Malaysia
Prior art keywords
paf
antagonists
imidazopyridine
formula
ring
Prior art date
Application number
MYPI92000223A
Other languages
English (en)
Inventor
Robert John Dr Bass
David Dr Alker
Kelvin Dr Cooper
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY108437A publication Critical patent/MY108437A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
MYPI92000223A 1991-02-13 1992-02-12 Imidazopyridine paf/h1 antagonists MY108437A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919102997A GB9102997D0 (en) 1991-02-13 1991-02-13 Therapeutic agents

Publications (1)

Publication Number Publication Date
MY108437A true MY108437A (en) 1996-09-30

Family

ID=10689943

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI92000223A MY108437A (en) 1991-02-13 1992-02-12 Imidazopyridine paf/h1 antagonists

Country Status (29)

Country Link
US (1) US5358953A (cg-RX-API-DMAC7.html)
EP (1) EP0572425B1 (cg-RX-API-DMAC7.html)
JP (1) JP2506541B2 (cg-RX-API-DMAC7.html)
KR (1) KR970005302B1 (cg-RX-API-DMAC7.html)
CN (1) CN1040326C (cg-RX-API-DMAC7.html)
AT (1) ATE109482T1 (cg-RX-API-DMAC7.html)
AU (1) AU650322B2 (cg-RX-API-DMAC7.html)
BR (1) BR9205615A (cg-RX-API-DMAC7.html)
CA (1) CA2099381C (cg-RX-API-DMAC7.html)
CZ (1) CZ280504B6 (cg-RX-API-DMAC7.html)
DE (1) DE69200304T2 (cg-RX-API-DMAC7.html)
DK (1) DK0572425T3 (cg-RX-API-DMAC7.html)
EG (1) EG20085A (cg-RX-API-DMAC7.html)
ES (1) ES2059212T3 (cg-RX-API-DMAC7.html)
FI (1) FI933531A7 (cg-RX-API-DMAC7.html)
GB (1) GB9102997D0 (cg-RX-API-DMAC7.html)
HU (2) HUT65947A (cg-RX-API-DMAC7.html)
IE (1) IE65125B1 (cg-RX-API-DMAC7.html)
IL (1) IL100887A (cg-RX-API-DMAC7.html)
MX (1) MX9200589A (cg-RX-API-DMAC7.html)
MY (1) MY108437A (cg-RX-API-DMAC7.html)
NO (1) NO300592B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ241597A (cg-RX-API-DMAC7.html)
PL (1) PL169304B1 (cg-RX-API-DMAC7.html)
RU (1) RU2114845C1 (cg-RX-API-DMAC7.html)
TW (1) TW227000B (cg-RX-API-DMAC7.html)
WO (1) WO1992014734A1 (cg-RX-API-DMAC7.html)
YU (1) YU48238B (cg-RX-API-DMAC7.html)
ZA (1) ZA921005B (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
AU3186395A (en) * 1994-08-10 1996-03-07 British Biotech Pharmaceuticals Limited Imidazopyridine derivatives as dual histamine (h1) and platelet activating factor (paf) antagonists
ES2087038B1 (es) * 1994-11-07 1997-03-16 Uriach & Cia Sa J Nuevas piperidinas con actividad antagonista del paf.
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
MX9707187A (es) * 1995-08-05 1997-11-29 British Biotech Pharm Derivados de imidazopiridina.
SE9801526D0 (sv) * 1998-04-29 1998-04-29 Astra Ab New compounds
ES2381775T3 (es) 2000-08-04 2012-05-31 Dmi Biosciences, Inc. Procedimiento del uso de dicetopiperazinas y composición que las contiene
CN101947306B (zh) 2003-05-15 2014-06-18 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
US7687515B2 (en) * 2006-01-17 2010-03-30 N.V. Organon 6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
TWI429641B (zh) 2008-01-30 2014-03-11 Nippon Zoki Pharmaceutical Co 哌啶衍生物
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ,インコーポレイテッド ジケトピペラジンを用いた医薬組成物
CN103619839B (zh) * 2011-06-28 2016-06-01 福建省闽东力捷迅药业有限公司 抗-变态反应的苯并环庚并噻吩衍生物
EP2765968A4 (en) 2011-10-10 2015-01-21 Ampio Pharmaceuticals Inc IMPLANTABLE MEDICINE PRODUCTS WITH INCREASED IMMUNO TOLERANCE AND PROCESSING AND IMPLANTATION METHODS
KR102032400B1 (ko) 2011-10-10 2019-10-15 앰피오 파마슈티컬스 인코퍼레이티드 퇴행성 관절 질환의 치료
SG10201605205VA (en) * 2011-10-28 2016-08-30 Ampio Pharmaceuticals Inc Treatment of rhinitis
KR20150132508A (ko) 2013-03-15 2015-11-25 앰피오 파마슈티컬스 인코퍼레이티드 줄기세포의 가동화, 회귀, 증식 및 분화를 위한 조성물 및 이의 사용 방법
EP4066836A1 (en) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
EP3310375A4 (en) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. USE OF LOW-MOLECULAR FRACTIONS OF HUMAN SERUMALBUMINE IN THE TREATMENT OF ILLNESSES
CN113880801A (zh) * 2020-07-03 2022-01-04 合肥医工医药股份有限公司 一类三环化合物、其制备方法及其医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (cg-RX-API-DMAC7.html) * 1963-04-24
AU616508B2 (en) * 1988-03-15 1991-10-31 G.D. Searle & Co. Benzyl-imidazo (4,5-c) pyridines
ATE141599T1 (de) * 1988-04-28 1996-09-15 Schering Corp Kondensierte polyzyklische verbindungen, zusammenstellungen, verfahren zur herstellung und deren anwendung als paf-antagonistische, antihistaminische und/oder anti-inflammatorische agenzien
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
CA2080476A1 (en) * 1990-05-09 1991-11-10 Anthony Marfat Azabenzimidazoles in the treatment of asthma, arthritis and related diseases

Also Published As

Publication number Publication date
CA2099381C (en) 1996-07-09
IL100887A0 (en) 1992-11-15
KR970005302B1 (ko) 1997-04-15
CN1040326C (zh) 1998-10-21
TW227000B (cg-RX-API-DMAC7.html) 1994-07-21
IE920449A1 (en) 1992-08-12
NO932889D0 (no) 1993-08-13
ES2059212T3 (es) 1994-11-01
FI933531A0 (fi) 1993-08-10
RU2114845C1 (ru) 1998-07-10
EP0572425B1 (en) 1994-08-03
ZA921005B (en) 1993-08-12
NO300592B1 (no) 1997-06-23
US5358953A (en) 1994-10-25
NO932889L (no) 1993-08-13
AU1168392A (en) 1992-09-15
NZ241597A (en) 1993-04-28
IL100887A (en) 1996-01-19
JP2506541B2 (ja) 1996-06-12
DE69200304D1 (de) 1994-09-08
CS42592A3 (en) 1992-09-16
DK0572425T3 (da) 1994-09-12
PL169304B1 (pl) 1996-06-28
FI933531L (fi) 1993-08-10
HUT65947A (en) 1994-08-29
EG20085A (en) 1997-05-31
JPH06504992A (ja) 1994-06-09
FI933531A7 (fi) 1993-08-10
IE65125B1 (en) 1995-10-04
HU9302327D0 (en) 1993-10-28
YU48238B (sh) 1997-08-22
EP0572425A1 (en) 1993-12-08
AU650322B2 (en) 1994-06-16
HU211202A9 (en) 1995-11-28
BR9205615A (pt) 1994-05-17
WO1992014734A1 (en) 1992-09-03
DE69200304T2 (de) 1994-12-08
ATE109482T1 (de) 1994-08-15
YU14392A (sh) 1994-11-15
CA2099381A1 (en) 1992-08-14
MX9200589A (es) 1992-10-01
GB9102997D0 (en) 1991-03-27
CN1064275A (zh) 1992-09-09
CZ280504B6 (cs) 1996-02-14

Similar Documents

Publication Publication Date Title
MY108437A (en) Imidazopyridine paf/h1 antagonists
UA26427A (uk) Похідhі ксаhтиhу у вигляді суміші ізомерів або іhдивідуальhих ізомерів, що мають властивість аhтагоhіста адеhозиhу
ES2167371T3 (es) Derivados de 1h-3-aril-pirrolidin-2,4-diona espirociclicos substituidos.
ES2062064T3 (es) Derivados de (hidroxi-1 piperidinil-2 alquil)indolonas-2, quinoleinas-2, benzo(b)acepinonas-2, bencimidaizonas-2 y quinazolinonas-2, su preparacion y su aplicacion en terapeutica.
IL69912A (en) Substituted 1-hydroxyethyltriazolyl derivatives,their preparation and their use as plant protection agents
UA41290C2 (uk) Гетероариламіни, фармацевтична композиція, спосіб інгібування холінестерази у ссавців, спосіб покращення пам'яті
GR3005072T3 (cg-RX-API-DMAC7.html)
AR247744A1 (es) Compuestos organosilano y catalizadores que contienen dichos compuestos
DK0510003T3 (da) Piperidin-og pyrrolidinderivater
DE3269272D1 (en) Organopolysiloxanes and their use as anti-foaming agents in aqueous dispersions and solutions of synthetic resins
NO164351C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-alkyl-l-fenyl-2-piperazinoalkylpyrazolin-3-on-forbindelser.
ES8303375A1 (es) Procedimiento para la fabricacion de derivados 2 substitui- dos del feniltiazol.
YU46589B (sh) Smeše kaučuka koje se mogu vulkanizovati
AU564799B2 (en) Composition for prophylactic and preventative of ketosis in livestock
TW225989B (cg-RX-API-DMAC7.html)
PH30229A (en) Pyridyl substituted benzothiazole compounds which has useful pharmaceutical utility
ES2062568T3 (es) Nuevos derivados de benzo (b) fenantrolinas-1,7 su preparacion y su aplicacion en terapeutica.
IE830686L (en) 1,2,5-thiadiazoles
IL62226A0 (en) Cephalosporins,their preparation and pharmaceutical compositions containing them
PT100223A (pt) Processo para a preparacao de imidazopiridinas antagonistas de paf/h1
FI973558L (fi) Menetelmä terapeuttisesti käytt¦kelpoisten 2-metyyli-imidatsoÄ4,5-cÜpyrid-1-yylijohdannaisten valmistamiseksi
MY103521A (en) Bicyclocatechol derivatives
IL67564A (en) 7-heteroaryl-(1,2)-fused 1,4-benzodiazepine compounds,their preparation and pharmaceutical compositions containing them
DE69001794D1 (de) Phenothiazinderivate, ihre herstellung und sie enthaltende pharmazeutische zusammensetzungen.
GB8315403D0 (en) Tetrahydro-beta-carboline derivatives